Predictive Biomarkers for Systemic Therapy of Hepatocellular Carcinoma

Scientists cover the recent advancements in the identification of proteomic/genomic/epigenomic/transcriptomic biomarkers for predicting hepatocellular carcinoma treatment efficacy with the use of multi-kinase inhibitors, CDK4/6 inhibitors, and immune checkpoint inhibitors.